http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0345572-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-19
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-16
filingDate 1989-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1991-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0345572-A3
titleOfInvention Sulfonamide derivatives, their preparation and pharmaceuticals containing them
abstract Sulfonamide derivatives of the formula I. in the R¹ represents a C₁₋₄ alkyl or phenyl group which can be substituted by halogen atoms, trifluoromethyl or C₁₋₄ alkyl groups, R² represents a hydrogen atom or a C₁₋₄ alkyl group, A represents one of the groups CHOR³, C = O, C = S or C = N-OR⁴, where R³ is a hydrogen atom, a C₁₋₄-alkyl, phenyl, benzyl or C₁₋₄-acyl group and R⁴ represents a hydrogen atom or a methyl group, B can mean an m- or p-position methylene, ethylene or, if A does not represent a carbonyl group, also a methyleneoxy group, the oxygen atom being bonded to the aromatics, E is a carboxyl, phosphonic acid or sulfonic acid residue, the physiologically acceptable salts thereof, esters with C₁₋₄ alcohols and amides, and the tetrazol-5-yl residue, their manufacture and use as medicines.
priorityDate 1988-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0031954-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0221344-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0194548-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407330845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834

Total number of triples: 51.